Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Characterisation of patient encounters in community pharmacies (with special focus on self-medication).

De Bolle L, Mehuys E, Christiaens T, Van Tongelen I, Remon JP, Boussery K.

Int J Pharm Pract. 2015 Jun;23(3):228-31. doi: 10.1111/ijpp.12138. Epub 2014 Aug 1.

PMID:
25082105
2.

Medication management among home-dwelling older patients with chronic diseases: possible roles for community pharmacists.

Mehuys E, Dupond L, Petrovic M, Christiaens T, Van Bortel L, Adriaens E, De Bolle L, Van Tongelen I, Remon JP, Boussery K.

J Nutr Health Aging. 2012 Aug;16(8):721-6. doi: 10.1007/s12603-012-0028-x.

PMID:
23076515
3.

[Self-medication of regular headache: a community pharmacy-based survey in Belgium].

Mehuys E, Paemeleire K, Van Hees T, Christiaens T, Van Bortel L, Van Tongelen I, Philippe G, Prévôt ML, Evrard B, Piette M, De Bolle L, Remon JP, Boussery K.

J Pharm Belg. 2012 Jun;(2):4-10. French.

PMID:
22978009
4.

Self-medication of regular headache: a community pharmacy-based survey.

Mehuys E, Paemeleire K, Van Hees T, Christiaens T, Van Bortel LM, Van Tongelen I, De Bolle L, Remon JP, Boussery K.

Eur J Neurol. 2012 Aug;19(8):1093-9. doi: 10.1111/j.1468-1331.2012.03681.x. Epub 2012 Feb 23.

5.

Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Giri M.

J Clin Pharm Ther. 2011 Oct;36(5):602-13. doi: 10.1111/j.1365-2710.2010.01218.x. Epub 2010 Dec 8.

PMID:
21143256
6.

[Management of COPD in community pharmacy].

Mehuys E, Boussery K, Adriaens E, Van Bortel L, De Bolle L, Van Tongelen I, Remon JP, Brusselle G.

J Pharm Belg. 2010 Mar;(1):10-5. French.

PMID:
20429390
7.

COPD management in primary care: an observational, community pharmacy-based study.

Mehuys E, Boussery K, Adriaens E, Van Bortel L, De Bolle L, Van Tongelen I, Remon JP, Brusselle G.

Ann Pharmacother. 2010 Feb;44(2):257-66. doi: 10.1345/aph.1M481. Epub 2010 Jan 26.

PMID:
20103611
8.

[Self-medication of upper gastrointestinal symptoms: a community pharmacy study].

Mehuys E, Verrue C, Van Borte L, De Bolle L, Van Tongelen I, Remon JP, De Looze D.

J Pharm Belg. 2009 Sep;(3):84-8. French.

PMID:
19873848
9.

Self-medication of upper gastrointestinal symptoms: a community pharmacy study.

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Remon JP, De Looze D.

Ann Pharmacother. 2009 May;43(5):890-8. doi: 10.1345/aph.1L647.

PMID:
19417113
10.

[Home medication cabinets and self-medication: a source of potential health threats].

De Bolle L, Verrue C, Mehuys E, Adriaens E, Remon JP, Van Bortel L, Christiaens T.

J Pharm Belg. 2009 Mar;(1):1-4. French. No abstract available.

PMID:
19391434
11.

Home medication cabinets and self-medication: a source of potential health threats?

De Bolle L, Mehuys E, Adriaens E, Remon JP, Van Bortel L, Christiaens T.

Ann Pharmacother. 2008 Apr;42(4):572-9. doi: 10.1345/aph.1K533. Epub 2008 Mar 25.

PMID:
18364405
12.

Effectiveness of pharmacist intervention for asthma control improvement.

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Brusselle G.

Eur Respir J. 2008 Apr;31(4):790-9. Epub 2007 Dec 19.

13.

Medication use and disease management of type 2 diabetes in Belgium.

Mehuys E, De Bolle L, Van Bortel L, Annemans L, Van Tongelen I, Remon JP, Giri M.

Pharm World Sci. 2008 Jan;30(1):51-6. Epub 2007 Jun 23.

PMID:
17588213
14.

Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses.

Naesens L, Stephens CE, Andrei G, Loregian A, De Bolle L, Snoeck R, Sowell JW, De Clercq E.

Antiviral Res. 2006 Oct;72(1):60-7. Epub 2006 Apr 18.

PMID:
16650489
15.

Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A.

Meeuwsen S, Persoon-Deen C, Bsibsi M, Bajramovic JJ, Ravid R, De Bolle L, van Noort JM.

J Neuroimmunol. 2005 Jul;164(1-2):37-47.

PMID:
15904975
16.

Update on human herpesvirus 6 biology, clinical features, and therapy.

De Bolle L, Naesens L, De Clercq E.

Clin Microbiol Rev. 2005 Jan;18(1):217-45. Review.

17.

Quantitative analysis of human herpesvirus 6 cell tropism.

De Bolle L, Van Loon J, De Clercq E, Naesens L.

J Med Virol. 2005 Jan;75(1):76-85.

PMID:
15543581
18.
19.

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle.

De Bolle L, Hatse S, Verbeken E, De Clercq E, Naesens L.

FEBS Lett. 2004 Feb 27;560(1-3):25-9.

20.

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.

De Bolle L, Andrei G, Snoeck R, Zhang Y, Van Lommel A, Otto M, Bousseau A, Roy C, De Clercq E, Naesens L.

Biochem Pharmacol. 2004 Jan 15;67(2):325-36.

PMID:
14698045
21.

Characterization of the catalytic subunit of the human herpesvirus 6 (HHV-6) DNA polymerase expressed in an in vitro transcription/translation assay.

De Bolle L, Balzarini J, De Clercq E, Naesens L.

Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):999-1001. No abstract available.

PMID:
14565330
22.

Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir.

De Bolle L, Michel D, Mertens T, Manichanh C, Agut H, De Clercq E, Naesens L.

Mol Pharmacol. 2002 Sep;62(3):714-21.

PMID:
12181449
23.

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J.

Rev Med Virol. 2001 Nov-Dec;11(6):381-95. Review.

PMID:
11747000
24.

Productive infection of primary macrophages with human herpesvirus 7.

Zhang Y, de Bolle L, Aquaro S, van Lommel A, De Clercq E, Schols D.

J Virol. 2001 Nov;75(21):10511-4.

25.

Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.

De Clercq E, Andrei G, Snoeck R, De Bolle L, Naesens L, Degrève B, Balzarini J, Zhang Y, Schols D, Leyssen P, Ying C, Neyts J.

Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):271-85. Review.

PMID:
11563039
26.

Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.

Neyts J, Naesens L, Ying C, De Bolle L, De Clercq E.

Antiviral Res. 2001 Feb;49(2):115-20.

PMID:
11248363

Supplemental Content

Loading ...
Support Center